Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Crude annual incidence rate of medullary thyroid cancer and RET mutation frequency.

Croatian medical journal - 30 Apr 2021

Milićević Sara, Bergant Damijan, Žagar Tina, Perić Barbara

Abstract excerpt

AIM: To determine the frequency and type of RET mutation in Slovenian medullary thyroid cancer (MTC) patients and estimate the crude annual incidence of MTC in Slovenia. METHODS: This referral-center retrospective analysis involved 186 MTC patients diagnosed between 1995 and 2015 and their relatives who underwent genetic counseling and testing. The crude incidence rate of MTC was estimated with the joinpoint...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Neuroendocrine
Share to Germ-Line Mutation
Share to Multiple Endocrine Neoplasia Type 2a

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation Rate

Share to Proto-Oncogene Mas

Share to Proto-Oncogene Proteins c-ret

Share to Slovenia

Share to Thyroid Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 33938650
PMCID: PMC8108000

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Crude annual incidence rate of medullary thyroid cancer and RET mutation frequency.PMID 33938650Read ↗

Diversity of mutations in the RET proto-oncogene and its oncogenic mechanism in medullary thyroid cancer.Semantic proximity Read ↗

RET proto oncogene mutation detection and medullary thyroid carcinoma prevention.Semantic proximity Read ↗

RET Proto-Oncogene Mutational Analysis in Patients With Medullary Thyroid CarcinomaSemantic proximity Read ↗

Novel RET Proto-oncogene variants identified in Turkish patients with thyroid carcinoma.Semantic proximity Read ↗

Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the RETSemantic proximity Read ↗

Molecular Analysis of the RET Proto-Oncogene Key Exons in Patients with Medullary Thyroid Carcinoma: A Comprehensive Study of the Iranian PopulationSemantic proximity Read ↗

RET Alterations Differentiate Molecular Profile of Medullary Thyroid Cancer.Semantic proximity Read ↗

Distribution of RET Mutations and Evaluation of Treatment Approaches in Hereditary Medullary Thyroid Carcinoma in Turkey.Semantic proximity Read ↗

RET Proto-Oncogene Variants in Patients with Medullary Thyroid Carcinoma from the Mediterranean Basin: A Brief ReportSemantic proximity Read ↗

Predominant RET Germline Mutations in Exons 10, 11, and 16 in Iranian Patients with Hereditary Medullary Thyroid CarcinomaSemantic proximity Read ↗

Hereditary medullary thyroid cancer in Slovenia--genotype-phenotype correlations.Semantic proximity Read ↗

A review of diagnostic approaches to medullary thyroid carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.